Close Menu

The BCW Index climbed 1.59 percent for the trading week ended Tuesday. Only five of the components of the Index declined for the week, and none of them dropped more than 1.6 percent. Stratagene led gainers for the tracking period, closing up 6.7 percent.

In comparison, the Dow Jones Industrial Average gained .9 percent, while both the Nasdaq and Nasdaq Biotech Index rose 2.6 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.